You are here: Industry Insights > COVID-19 vaccine

News List

J&J accelerates clinical trial of investigational COVID-19 vaccine europeanpharmaceuticalreview
June 15, 2020
The investigational SARS-CoV-2 vaccine developed by J&J is now due to start its Phase I/IIa clinical trial at the end of July.
Panacea Biotec and Refana team up for Covid-19 vaccine pharmaceutical-technology
June 15, 2020
India-based Panacea Biotec has partnered with Refana USA for the development, manufacturing and distribution of a Covid-19 vaccine candidate worldwide.
Oxford Biomedica Signs Collaboration Agreement with VMIC contractpharma
June 15, 2020
Will work collaboratively to enable the manufacture of viral vector-based vaccines.
Valor Glass Packaging Selected to Accelerate Delivery of COVID-19 Vaccines contractpharma
June 15, 2020
Corning to receive $204 million in funding to expand domestic manufacturing capacity under White House’s Operation Warp Speed Initiative.
European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing expresspharma
June 12, 2020
mRNA vaccines consist of genetic material, called messenger RNA, that provides instructions for a human cell to make a target protein, or immunogen, which activates the body’s immune response against the respective virus.
Johnson & Johnson announces acceleration of its COVID-19 vaccine candidate; Phase 1/2a clinical trial to begin in second half of July worldpharmanews
June 11, 2020
Johnson & Johnson announced that through its Janssen Pharmaceutical Companies (Janssen) it has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of its investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant.
Panacea Biotec and Refana Collaborate for COVID-19 Vaccine contractpharma
June 11, 2020
Partnership will enable global development, manufacturing and distribution of the candidate COVID-19 vaccine.
Dyadic to Develop Cell Lines for COVID-19 Vaccine Candidates contractpharma
June 11, 2020
Selected by the Frederick National Laboratory to engineer proprietary C1 cell lines.
Panacea Biotec and Refana announce landmark collaboration for COVID-19 vaccine expresspharma
June 10, 2020
Collaboration will enable global development, manufacturing and distribution of the Candidate COVID-19 vaccine.
Serum Institute to invest $100 million on potential COVID-19 vaccine expresspharma
June 10, 2020
It has partnered with AstraZeneca, a British company, to ensure equitable supply of the AZD1222 vaccine doses to India as well as low-and-middle-income countries.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page